NCT01376284View on ClinicalTrials.gov

Drug Use Investigation for AVOLVE(BPH)

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

October 31, 2013

Study Completion Date

June 30, 2014

Conditions
Prostatic Hyperplasia
Interventions
DRUG

Dutasteride

Collection of safety data

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01376284 - Drug Use Investigation for AVOLVE(BPH) | Biotech Hunter | Biotech Hunter